Quick Summary:
In the dynamic world of biopharmaceuticals, understanding the Antibody-drug Conjugate Therapeutics market is critical to stay ahead of the curve. Our market research report provides comprehensive analysis of the sector across various geographies such as North America, South America, Asia & Pacific, Europe, and MEA. It also includes valuable data from key countries like the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil.
Our report presents detailed profiles of global key players in the domain along with insightful SWOT analysis. It offers a deep dive into various types of Antibody-drug Conjugate Therapeutics, elucidating their performance trends and market share. With data spanning from 2018 and forecast until 2028, our report is a valuable asset for making informed business decisions and strategic planning. Beyond figures, it provides an understanding of the larger patterns and forces shaping this crucial market sector.
For the geography segment, regional supply, demand, major players, and price is presented from 2019 to 2029.
This report covers the following regions:
- North America
- South America
- Asia & Pacific
- Europe
- MEA
For the competitor segment, the report includes key players of Antibody-drug Conjugate Therapeutics as well as some small players.
The information for each competitor includes:
- Company Profile
- Business Information
- SWOT Analysis
- Revenue, Gross Margin and Market Share
Types Segment:
- Gemtuzumab ozogamicin
- Brentuximab vedotin
- Trastuzumab emtansine
- Inotuzumab ozogamicin
- Polatuzumab vedotin
- Enfortumab vedotin
- Trastuzumab deruxtecan
- Sacituzumab govitecan
- Belantamab mafodotin
- Moxetumomab pasudotox
- Loncastuximab tesirine
Companies Covered:
- ADC Therapeutics SA
- Astellas Pharma Inc.
- AstraZeneca plc
- Daiichi Sankyo Company Ltd.
- Genentech Inc.
- Gilead Sciences
- GlaxoSmithKline
- Pfizer
- Rakuten Medical Inc.
- Seagen
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- ADC Therapeutics SA
- Astellas Pharma Inc.
- AstraZeneca plc
- Daiichi Sankyo Company Ltd.
- Genentech Inc.
- Gilead Sciences
- GlaxoSmithKline
- Pfizer
- Rakuten Medical Inc.
- Seagen
- Inc.
Methodology
LOADING...
